CPC C07K 14/7051 (2013.01) [A61K 9/19 (2013.01); A61K 35/17 (2013.01); A61K 39/001111 (2018.08); A61P 35/00 (2018.01); C07K 14/70539 (2013.01); C07K 16/2809 (2013.01); C07K 16/2833 (2013.01); C12N 5/0638 (2013.01); C12N 15/115 (2013.01); G01N 33/57492 (2013.01); G16B 25/10 (2019.02); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C12N 2310/16 (2013.01)] | 20 Claims |
1. A method of treating a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present a peptide consisting of the amino acid sequence of RPILKEQSSSSF (SEQ ID NO: 246), wherein said cancer is selected from the group consisting of gallbladder cancer, head and neck squamous cell carcinoma, squamous cell non-small cell lung cancer, and esophageal cancer.
|